PL143070B1 - Method of obtaining novel hidantoine derivatives - Google Patents

Method of obtaining novel hidantoine derivatives Download PDF

Info

Publication number
PL143070B1
PL143070B1 PL1984242850A PL24285084A PL143070B1 PL 143070 B1 PL143070 B1 PL 143070B1 PL 1984242850 A PL1984242850 A PL 1984242850A PL 24285084 A PL24285084 A PL 24285084A PL 143070 B1 PL143070 B1 PL 143070B1
Authority
PL
Poland
Prior art keywords
spiro
compounds
trione
imidazolidine
group
Prior art date
Application number
PL1984242850A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL143070B1 publication Critical patent/PL143070B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
PL1984242850A 1983-05-25 1984-05-23 Method of obtaining novel hidantoine derivatives PL143070B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (1)

Publication Number Publication Date
PL143070B1 true PL143070B1 (en) 1988-01-30

Family

ID=23979057

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1984242850A PL143070B1 (en) 1983-05-25 1984-05-23 Method of obtaining novel hidantoine derivatives
PL1984247804A PL143290B1 (en) 1983-05-25 1984-05-23 Process for preparing imidazolydinodionic derivatives
PL25285084A PL252850A1 (en) 1983-05-25 1984-05-23 Method of obtaining hydantoine derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL1984247804A PL143290B1 (en) 1983-05-25 1984-05-23 Process for preparing imidazolydinodionic derivatives
PL25285084A PL252850A1 (en) 1983-05-25 1984-05-23 Method of obtaining hydantoine derivatives

Country Status (19)

Country Link
US (1) US4464380A (OSRAM)
EP (1) EP0127412B1 (OSRAM)
JP (1) JPS604183A (OSRAM)
KR (1) KR860001869B1 (OSRAM)
AT (1) ATE57531T1 (OSRAM)
AU (1) AU543916B2 (OSRAM)
CA (1) CA1266270A (OSRAM)
DE (1) DE3483402D1 (OSRAM)
DK (1) DK163924C (OSRAM)
ES (2) ES532736A0 (OSRAM)
FI (1) FI78699C (OSRAM)
GR (1) GR82020B (OSRAM)
HU (1) HU190548B (OSRAM)
IE (1) IE57520B1 (OSRAM)
IL (1) IL71904A (OSRAM)
PH (1) PH21151A (OSRAM)
PL (3) PL143070B1 (OSRAM)
PT (1) PT78625A (OSRAM)
YU (2) YU43931B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3565105D1 (en) * 1984-08-20 1988-10-27 Pfizer Process for the production as asymmetric hydantoins
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
ES2187603T3 (es) * 1995-10-18 2003-06-16 Hoffmann La Roche Hidroximetilacion de tocoferoles.
US7148214B1 (en) 1998-12-19 2006-12-12 Janssen Pharmaceutica, N.V. Antihistaminic spiro compounds
JP2009526044A (ja) * 2006-02-07 2009-07-16 アストラゼネカ・アクチエボラーグ 新規な化合物ｉ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
YU89784A (en) 1987-04-30
IL71904A0 (en) 1984-09-30
FI842079A0 (fi) 1984-05-24
EP0127412B1 (en) 1990-10-17
DK250084A (da) 1984-11-26
EP0127412A2 (en) 1984-12-05
PH21151A (en) 1987-07-30
IE841294L (en) 1984-11-25
FI78699C (fi) 1989-09-11
KR840009101A (ko) 1984-12-24
ES8600764A1 (es) 1985-10-16
ES532736A0 (es) 1985-10-16
ES8607304A1 (es) 1986-06-01
EP0127412A3 (en) 1987-09-02
YU43931B (en) 1989-12-31
DK163924C (da) 1992-09-14
CA1266270A (en) 1990-02-27
PL143290B1 (en) 1988-02-29
IE57520B1 (en) 1993-05-19
AU2856384A (en) 1984-11-29
ES540858A0 (es) 1986-06-01
PL252850A1 (en) 1985-11-19
PT78625A (en) 1984-06-01
HU190548B (en) 1986-09-29
YU43958B (en) 1989-12-31
PL247804A1 (en) 1985-08-13
KR860001869B1 (ko) 1986-10-24
FI842079A7 (fi) 1984-11-26
ATE57531T1 (de) 1990-11-15
IL71904A (en) 1988-01-31
DE3483402D1 (de) 1990-11-22
HUT34194A (en) 1985-02-28
AU543916B2 (en) 1985-05-09
US4464380A (en) 1984-08-07
DK250084D0 (da) 1984-05-22
JPH0573754B2 (OSRAM) 1993-10-15
DK163924B (da) 1992-04-21
FI78699B (fi) 1989-05-31
JPS604183A (ja) 1985-01-10
YU212286A (en) 1987-10-31
GR82020B (OSRAM) 1984-12-12

Similar Documents

Publication Publication Date Title
EP1347979B1 (en) Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
CS199690B2 (cs) Způsob výroby spiro-hydantoinových derivátů
US4127665A (en) Thienohydantoin derivatives
EP0034063B1 (en) Hydantoin amines and pharmaceutical compositions thereof
PL110460B1 (en) Method of producing new,optically active derivatives ofhydantoin
JPS607997B2 (ja) ヒダントイン誘導体治療剤
KR900000552B1 (ko) 항알레르기 및 소염 제제와 그의 제조방법
US4235911A (en) Hydantoin derivatives
PL143070B1 (en) Method of obtaining novel hidantoine derivatives
PL147397B1 (en) Method of obtaining novel derivatives of spiro imidazolidine
EP0159143B1 (en) Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
EP0028485B1 (en) Spiro-imidazolones for alleviating diabetes-associated conditions, processes for preparing them, and pharmaceutical compositions containing them
EP0204534B1 (en) Quinazolinone compounds and processes for the preparation thereof
EP0065393B1 (en) Pyrrole derivatives
PL142143B1 (en) Method of obtaining novel spiro-3-heteroazolydinodiones
EP0014079A1 (en) Spiro-quinolylhydantoins, process for their preparation and pharmaceutical compositions thereof
EP0168181B1 (en) Cyclic amides
EP0094184A1 (en) Indoline derivatives
US4539329A (en) 7'-Trifluoromethyl-spiro[imidazolidine-4,3'-indoline]-2,2',5-triones as aldose reductase inhibitors
US4273775A (en) Hydantoin derivatives, anti-diabetic compositions thereof, and method of use thereof
PT87307B (pt) Processo para a preparacao de quinoxalil-imidazolidino-2,4-dionas substituidas e de composicoes farmaceuticas que as contem
PL152316B1 (en) Method of obtaining novel spiroheteroazolones
KR860001870B1 (ko) 이미다졸리딘디온 유도체의 제조방법
PL147875B1 (en) Method of obtaining derivatives of tetracyclic spirolohydantoine
PL156798B1 (pl) Sposób wytwarzania nowych pochodnych imidazolidyno- piranopirydynodionu PL PL PL